Fine-tuning m6A and METTL3 levels have profound impact on cellular proliferation and protein synthesis
This study demonstrates that in basal-like triple-negative breast cancer, the dose-dependent regulation of m6A by METTL3 critically controls cellular proliferation and protein synthesis, where partial loss of METTL3 paradoxically enhances translation and growth while strong inhibition suppresses them.